@ARTICLE{
author={Lentz SR,Cerqueira MH,Janic Dragana M,Kempton CL,Matytsina Irina,Misgav M,Oldenburg J,Ozelo M,Recht M,Rosholm A,Savic Aleksandar D,Suzuki Takashi,Tiede Andreas,Santagostino E},
year={2016},
title={Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A},
journal={HAEMOPHILIA},
volume={22},
number={5},
pages={E445-E449},
document_type={Letter},
}